BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:72f0efa4-a4ee-4d29-a85f-68cde4de6770
DTSTAMP:20250702T142601
DTSTART:20251010T140000
DTEND:20251010T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:5c0eb721-5aa9-4a8a-8901-6cff6136709c
DTSTAMP:20250702T142601
DTSTART:20251016T100000
DTEND:20251016T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:Module: PHA403, Person delivering: Dagan/ Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:2965a6dd-f0cb-4c42-958f-1c2d567f399b
DTSTAMP:20250702T142601
DTSTART:20251024T110000
DTEND:20251024T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:b438690f-4b41-4c13-9b45-8cfd4bd0831b
DTSTAMP:20250702T142601
DTSTART:20251024T120000
DTEND:20251024T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:f7fcfd4d-43bf-4af6-ba13-adc3725b55bd
DTSTAMP:20250702T142601
DTSTART:20251030T150000
DTEND:20251030T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:5309dd93-dd53-42f2-8af6-0db5a1952e30
DTSTAMP:20250702T142601
DTSTART:20251104T140000
DTEND:20251104T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:22cc0630-6e73-4a38-82e1-9e8c6a740447
DTSTAMP:20250702T142601
DTSTART:20251104T150000
DTEND:20251104T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:5c156279-26bf-4452-9d00-465623c1991d
DTSTAMP:20250702T142601
DTSTART:20251111T130000
DTEND:20251111T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:1cb90e2c-b3fb-4478-9793-eeef5442444a
DTSTAMP:20250702T142601
DTSTART:20251111T140000
DTEND:20251111T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:c99d3f52-7c84-4b1c-b2da-e860470a80d1
DTSTAMP:20250702T142601
DTSTART:20251114T100000
DTEND:20251114T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:1ce47888-ceaa-44b2-b441-955eb8222cf0
DTSTAMP:20250702T142601
DTSTART:20251114T110000
DTEND:20251114T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:743a59e4-9573-42b3-af71-a2a92bad2201
DTSTAMP:20250702T142601
DTSTART:20251120T120000
DTEND:20251120T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:0f652add-537b-44e9-8ab2-800f6d41a808
DTSTAMP:20250702T142601
DTSTART:20251127T110000
DTEND:20251127T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:f05d0bb7-961e-4606-ab77-f5b0e461faff
DTSTAMP:20250702T142601
DTSTART:20251127T120000
DTEND:20251127T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:0e0fb59a-62fc-4027-bf3e-d52ac027234a
DTSTAMP:20250702T142601
DTSTART:20251127T140000
DTEND:20251127T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:Module: PHA403, Person delivering: Dagan, Toqa, Jen
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:9bb2e244-8d1b-43d1-ae5c-1b5d2a385783
DTSTAMP:20250702T142601
DTSTART:20251128T140000
DTEND:20251128T150000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:efbc9c26-1dab-4629-878a-fc88dcff3b94
DTSTAMP:20250702T142601
DTSTART:20251128T150000
DTEND:20251128T160000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:301d8249-4dc2-4fc3-89ec-bf3fee4e2dd1
DTSTAMP:20250702T142601
DTSTART:20260105T140000
DTEND:20260105T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:10d4bb47-2edb-4e3e-abe3-6c79f5f4d183
DTSTAMP:20250702T142601
DTSTART:20260105T150000
DTEND:20260105T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:d0099d8e-f66d-4360-b1a8-7d87def9ee15
DTSTAMP:20250702T142601
DTSTART:20260115T150000
DTEND:20260115T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:1b494066-662f-4eb7-b262-8ff950d7ef17
DTSTAMP:20250702T142601
DTSTART:20260203T100000
DTEND:20260203T110000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 1 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:5574b1fd-53b9-4f2f-bfa7-088b9dcebb90
DTSTAMP:20250702T142601
DTSTART:20260203T110000
DTEND:20260203T120000
SUMMARY:PK 2.1 Non-compartmental analysis
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:c0ba070f-f81f-478d-9eb6-0f95abbfe523
DTSTAMP:20250702T142601
DTSTART:20260203T120000
DTEND:20260203T130000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 2 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:fcc400da-cb30-4145-a889-71c6e8354adb
DTSTAMP:20250702T142601
DTSTART:20260212T120000
DTEND:20260212T130000
SUMMARY:PK 2.2 Introduction to PK of biologics
DESCRIPTION:Module: PHA403, Person delivering: Reya
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:3af1c406-981c-4447-bf54-91c0e481f610
DTSTAMP:20250702T142601
DTSTART:20260226T110000
DTEND:20260226T120000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:3c3aff5d-082c-4a5e-9f8a-ab4d5d949bad
DTSTAMP:20250702T142601
DTSTART:20260226T120000
DTEND:20260226T130000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:6e352591-287b-4ebe-80db-4afe5d2a3078
DTSTAMP:20250702T142601
DTSTART:20260317T110000
DTEND:20260317T120000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:b18dad3e-cc80-427e-9ec6-06b34a2d87cc
DTSTAMP:20250702T142601
DTSTART:20260317T120000
DTEND:20260317T130000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:e64ff5e9-a250-4f80-9d32-764a085ca454
DTSTAMP:20250702T142601
DTSTART:20260515T120000
DTEND:20260515T130000
SUMMARY:PK 2.5 Bioequivalence 1
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Lecture theatre F
END:VEVENT
BEGIN:VEVENT
UID:0e8a4b66-7a13-4fcb-a9a1-d065276fd313
DTSTAMP:20250702T142601
DTSTART:20260529T100000
DTEND:20260529T110000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:1625a2de-55e0-44d7-9fce-f96a589d7b7a
DTSTAMP:20250702T142601
DTSTART:20260529T110000
DTEND:20260529T120000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:64ed5c87-8784-4d5f-9218-c65dca86fe8b
DTSTAMP:20250702T142601
DTSTART:20260529T120000
DTEND:20260529T130000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
END:VCALENDAR
